Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2015 Jul 15.
Published in final edited form as: Exp Cell Res. 2014 Jan 30;325(2):148–154. doi: 10.1016/j.yexcr.2014.01.018

Multifunctional ECM proteins in bone and teeth

Sriram Ravindran 1,2, Anne George 1,2,*
PMCID: PMC4072740  NIHMSID: NIHMS562119  PMID: 24486446

Abstract

The extracellular matrix (ECM) of all tissues and organs is a highly organized and complex structure unique to the specific organ type. The ECM contains structural and functional proteins that define cellular function, organization, behavior and ultimately organ characteristics and function. The ECM was initially thought to contain only a specific set of secretory proteins. However, our group and several other groups have shown that the ECM contains functional proteins that have been previously defined as solely intracellular. In the present review, we have focused on the ECM of mineralized tissues namely: bone and dentin. We provide here, a brief review of some non-classical ECM proteins that have been shown to possess both intra and extracellular roles in the formation of these mineralized matrices.

Introduction

Most of the tissues that constitute a living organism consist of live cells embedded within an extracellular matrix (ECM). ECM constitutes the non-cellular component of tissues and is composed of structural and functional proteins (1). Each tissue has a unique ECM signature that provides instructional cues for cellular differentiation, migration, wound healing and immune response. Briefly, the ECM determines tissue functionality. Recent tissue engineering strategies have focused on mimicking the composition of the ECM to achieve desired cellular behavior and lineage specific differentiation to facilitate regeneration of tissues such as bone, dental pulp and cartilage (25). The primary reason behind such approaches lies in the complex nature of the ECM. As the ECM is dynamic, it is difficult to determine the exact components and composition of the ECM matrix. Recently, several unknown and multifunctional proteins previously thought to be intracellular are being identified and classified as functional proteins in the ECM. The goal of this review is to focus on novel multi-functional extracellular matrix proteins that contribute to the formation of mineralized tissues namely; bone and dentin.

Bone and dentin are complex mineralized tissues generated by osteoblasts and odontoblasts respectively. The main function of the osteoblast and odontoblast cells is to form mineralized matrices by secretion of collagenous and noncollagenous proteins as well as mediators of mineralization. Although similar in many ways, the ECM of bone and dentin has several significant differences with respect to their composition and function. Bone has recently been characterized as an endocrine organ (6). Osteoblasts and osteocytes produce two hormones, namely, fibroblast growth factor 23 (FGF23) and osteocalcin that function as endocrine hormones regulating kidney function and insulin secretion respectively. Although not characterized as an endocrine organ, odontoblast cells have also been shown to express FGF23 (7) and osteocalcin. Similarly, both tissues express growth factors belonging to the bone morphogenetic protein/transforming growth factor beta (BMP/TGFβ) superfamily, fibroblast growth factors (FGFs), vascular endothelial growth factors (VEGFs) (8,9), phosphatases and metalloproteases. However, the responses of osteoblasts and odontoblasts to these growth factors are different. For example, expression of the transcription factor Runx2 is triggered by treatment of osteoblasts with BMP/TGFβ superfamily of proteins. However, the same response is elicited by odontoblasts when treated with FGFs.

In this review, we have attempted to stress the importance of multifunctional proteins in the formation and maintenance of mineralized tissues. Advances in science dictate that nature behaves in a conservative manner. This implies that large amount of work is accomplished with minimal effort. In the biological system, this is facilitated by the use of multifunctional proteins. Therefore, this review focuses on the multifunctional proteins highlighted below that influences stem cell differentiation and matrix mineralization.

Dentin matrix protein 1 (DMP1)

DMP1 is an acidic phosphorylated non-collagenous protein (NCP) that is present in the ECM of bone and dentin. Although initially isolated from the dentin matrix, DMP1 is present in all mineralized tissue matrices. Loss of DMP1 function causes rickets and osteomalacia (10) characterized by hypo-mineralized tissues and abnormal phosphate regulation influenced by altered FGF23 expression (10). In bone, DMPl is a target molecule for the important osteoblast transcription factor runx 2 (11). In the ECM, DMPl binds calcium and initiates nucleation of crystalline hydroxyapatite (12,13).

Apart from its role in matrix mineralization, DMPl can act as both intra and extracellular signaling molecule impacting osteoblast and odontoblast differentiation at several stages of development. DMPl possesses a functional nuclear localizing signal (NLS) that enables intracellular nuclear translocation of the protein (14). In the nucleus, DMPl binds to DSPP promoter and influences odontogenic differentiation of precursor odontoblasts by controlling DSPP expression (15). As an extracellular signaling molecule, MMP2 cleaved fragments of DMPl influence stem cell differentiation (16). Extracellular DMPl is endocytosed via the cell surface receptor GRP78 (17). Endocytosis of DMPl triggers calcium mediated signaling resulting in differentiation of precursor mesenchymal cells (18). DMPl tethered to the ECM can initiate integrin mediated signaling via the α5β3 cell surface integrin and contribute to the ECM-osteocyte signaling mechanisms via the mitogen activated protein kinase (MAPK) pathway (19).

Collectively, the published data on this multi-functional protein indicates that DMPl can play several roles at various stages of development of mineralized tissues starting from modulation of lineage specific differentiation of mesenchymal stem cells to nucleation of crystalline hydroxyapatite.

Dentin Phosphophoryn (DPP)

DPP is a member of the small integrin binding ligand, N-linked glycoproteins (SIBLING). DPP is predominantly expressed by odontoblasts and is the most abundantly expressed non-collagenous protein in the dentin matrix. DPP is also present in the bone matrix, but in extremely small amounts (20). DPP and dentin sialoprotein (DSP) are both encoded by the gene DSPP (21). The creation of DPP protein from DSPP mRNA is a topic of debate with several suggested mechanisms (2224). We have recently identified an active internal ribosomal entry site (IRES) in the DSPP gene that might result in the production of DPP protein. As a result of this, the DPP protein would lack a signal peptide and therefore, will have to be secreted via non-classical secretory pathways.

The primary function of DPP in the matrix is to initiate nucleation of hydroxyapatite crystals (2528). However, recently, DPP has been shown to possess signaling functions that can initiate lineage specific differentiation of mesenchymal stem cells (29). DPP in the ECM can mediate cell adhesion and initiate integrin mediated signaling (30,31). Additionally, DPP can also initiate calcium and calmodulin dependent signaling to promote differentiation of precursor mesenchymal cells (32). The acidic domain in DPP facilitates non-classical endocytosis of the protein (33). Although the acidic domain by itself does not possess any signaling bioactivity, we can speculate that some of the signaling roles of DPP can be attributed to the endocytosis of the protein.

Therefore, DPP is a multi faceted protein with proven roles in matrix mineralization and signaling. Further studies are required to completely understand its intracellular role in preodontoblasts.

Osteopontin (OPN)

Osteopontin is a highly phosphorylated sialoprotein found in the ECM of bone and teeth (34). Similar to DMP1 and DPP, It is a member of the SIBLING family of noncollagenous proteins (35). Although initially identified in the ECM of bone, OPN is one of the most extensively studied SIBLING proteins and performs several functions in several tissues ranging from development to signaling roles in cancer based on its phosphorylation state (36,37). With respect to matrix mineralization, OPN binds calcium avidly and is a key regulator of hydroxyapatite nucleation.

OPN is an interfacial ECM protein and can be localized to the interfaces of cell and ECM and also in the cement lines (matrix-matrix interface) (38). This specific localization pattern was postulated to be important for minimizing strain induced fatigue damage and micro crack propagation (38) and has recently been verified experimentally using a knock-out mouse model (39). The contribution of OPN to mineralized matrix formation lies in its ability to control bone quality and not just bone mass (39). OPN can influence osteoclast attachment and facilitate matrix mineralization by influencing the shape and size of the hydroxyapatite crystals (4042).

Phosphorylation and other post-translational modifications control the various functions of OPN. For example, with respect to matrix mineralization, OPN from bone containing 13 phosphorylated serines inhibit hydroxyapatite nucleation. On the other hand, milk derived OPN containing 28 phosphorylated serines promote nucleation (43). Additionally, OPN can also be proteolytically processed by preoteases such as PHEX, thrombin, matrix metalloprotease 2 (MMP2), MMP3 and MMP7 giving rise to several bioactive peptides with distinct functions (44,45).

Apart from its direct role in matrix mineralization, OPN also possesses signaling functions. The RGD domain in OPN binds to α4β1 integrin and triggers a cell type specific integrin mediated signaling cascade. Interestingly, OPN possesses a transglutaminase (TG) binding domain and a recent study shows that oligomerization of OPN by TG2 enhances its ability to promote integrin mediated osteoblast attachment (46). Apart from outside-in signaling functions, intracellular isoforms of OPN generated by alternate translation can initiate intracellular signaling functions in several cell types such as macrophages, dendritic cells, lymphocytes, T-cells and osteoclasts and via its interactions with CD44 intra and extracellularly (4750). Finally, OPN has been localized to the nucleus of 293T cells linked to polio-like kinase-1 playing a role in duplication of the 293T cells (51).

OPN is one of the most extensively studied ECM proteins that has been shown to be truly multifunctional with several functional roles in various cell types. With respect to mineralized tissues, OPN serves to both promote and inhibit nucleation of hydroxyapatite at various stages and synergistically performs its signaling functions using its RGD motif and proteolytic fragments to promote osteoclast or osteoblast activity depending on the biological context.

Periostin

Periostin is a 90KDa matricellular protein expressed by preodontoblasts, osteoblasts and osteocytes. Originally, periostin was identified in osteoblasts as osteoblast specific factor -2 as a protein that plays a role in preosteoblast cell adhesion (52). Although initially localized in the periosteum of bone, cell types subjected to mechanical strains such as the periodontal ligament and tendons express this protein (53).

The localization of periostin preferentially in collagen rich tissues such as bone and dentin implicates a role for this protein in bone biology and regeneration (53). In bone periostin is expressed during embryonic development and bone growth in the periosteum and plays an important role in controlling the cortical thickness of the bone. In adult animals, periostin expression is observed in bone fractures or mechanical injury (53).

In the tooth, periostin is expressed by ameloblasts, preodontoblasts, odontoblasts and periodontal ligament cells (54). Periostin knockout mice display ectopic mineralization and hypermineralized dentin (54) suggesting that periostin is a negative regulator of matrix mineralization. Additionally, periostin is negatively regulated upon in vitro mechanical loading and TGFβ stimulation further confirming its role as a negative regulator of matrix mineralization.

In all mineralizing tissues, periostin plays a significant role in the crosslinking of collagen fibrils and ECM organization by binding directly to type I collagen and also to fibronectin and tenascin-C in the matrix (53). Periostin possesses a heparin-binding domain. This fact coupled with its association with fibronectin presents an interesting possibility of periostin serving as a reservoir for heparin binding growth factors, glycoproteins and proteoglycans (55).

From a signaling perspective, periostin regulates MMP-2 expression via the α5β3 integrin mediated signaling pathway in periodontal ligament cells. Additionally, an isoform of periostin (isoform 3) has been localized in the nucleus of developing tissues (56). A role for periostin in the nucleus is yet to be determined.

All of these evidences suggest that periostin functions as a negative regulator of mineralization, however, its signaling function is responsible for the organization of the ECM matrix.

Glucose regulated protein 78 (GRP78)

GRP78, also known as heat shock protein a5 (hspa5) is a member of the 70KDa heat shock protein family. GRP78 is an endoplasmic reticulum (ER) stress response protein that facilitates folding and assembly of secretory and membrane proteins. Published reports indicate increased production and membrane localization of GRP78 by cells that have been challenged with toxins, cancer, calcium stress or apoptotic agents (5760). On the plasma membrane, GRP78 resides within lipid rich surfaces and localizes to detergent resistant membrane fractions during purification (61,62). Although GRP78 has been extensively studied for its role in cancer cell survival and as a target for cancer therapy, its role in mesenchymal cells and mineralized tissue formation has only recently been studied.

Cells involved in the formation of a mineralized matrix are under constant calcium induced stress leading to increased production of the stress response genes including GRP78. We have shown that GRP78 can be localized to the plasma membrane of both pre-osteoblast and pre-odontoblast cells. As a membrane resident protein, GRP78 functions as a receptor for DMPl facilitating its endocytosis and the subsequent calcium related signaling events associated with it (17,18). This is a recently identified role for this already multi- functional protein in mesenchymal cells.

Further, we have shown that GRP78 secretion also increased upon induction of osteogenic or odontogenic differentiation of respective precursor mesenchymal cells (63). In vitro binding experiments indicated that GRP78 binds to type I collagen and DMPl. When both ligands are present together, its binding affinity to type I collagen is greater and saturates first before binding to DMPl saturates. Subsequent calcium phosphate nucleation experiments indicated that GRP78 induces nucleation of amorphous calcium phosphate by itself, when bound to type I collagen and when bound to demineralized dentin wafers (63). These results corroborated well with the developmental expression pattern of GRP78 confirming its role in the formation of mineralized matrices (64).

Additionally, we have observed the presence of GRP78 in the nucleus of terminally differentiated odontoblasts. Further investigations are necessary to ascertain its role in the nucleus of differentiated cells. Overall, this stress chaperone that was once thought to be an intracellular heat shock protein has emerged as one with very diverse roles in several cell types ranging from survival to matrix mineralization. In mineralizing tissues, we envision that GRP78 plays different roles during various developmental stages. GRP78 by itself does not possess any bioactivity as a signaling molecule, but can guide differentiation of precursor mesenchymal cells by serving as a receptor for DMP1. During later stages of matrix mineralization GRP78 can bind to type I collagen matrix directly or to DMP1 bound to the collagen matrix to initiate or support matrix mineralization.

TGFβ receptor II (TGFβR2) interacting protein 1 (TRIP1)

TRIP1 is a member of the WD40 repeat containing family of proteins. This group of proteins play important roles in signal transduction, vesicular trafficking and cell cycle regulation (65,66). TRIP1 binds to the cytoplasmic domain of TGFβR2 and influences TGFβ signaling by acting as a negative regulator and inhibiting positive regulation of TGFβ target genes (67). Published data shows that overexpression of TRIP1 in mesenchymal cells triggered better differentiation of these cells under mineralization conditions in the presence of ascorbic acid, organic β-glycerophosphate and dexamethasone (68). Additionally, TRIP1 can be detected in the secretome of mesenchymal cells and can initiate nucleation of calcium phosphate polymorphs in vitro (6869).

TRIP1 plays an active role in TGFβ mediated signaling. Therefore, it is conceivable that TRIP1 might affect this signaling pathway. Further studies are required to explore the possibilities of its effect on TGFβ signaling on mesenchymal stem cell differentiation and matrix mineralization.

Identifying the localization and function of TRIP1 in mineralized matrix formation has paved the way for inclusion of TRIP1 into the group of multifunctional proteins that possess extra and intracellular roles in controlling the complex process of stem cell differentiation and matrix mineralization.

Concluding Remarks

With respect to mineralized tissue biology, the ECM of bone and dentin are comprised of a multitude of proteins. Using the present technology it will be a daunting task to identify the exact composition of these matrices. Recent proteomic studies have shown that the ECM of mineralized tissues is comprised of thousands of proteins ranging from structural proteins to transcription factors (70). Recently proteins that have been previously thought to be intracellular only have been identified in the ECM with unique functions that complement their intracellular roles.

With the focus of this review being multifunctional ECM proteins in mineralized tissues, we have described the multifunctional roles of DMP1 and DPP that serve as positive regulators of mineralization and also are involved in several signaling mechanisms across different stages of development. On the other hand, we have also provided an overview of the multifunctional OPN and periostin that are considered to be negative regulators of hydroxyapatite nucleation and also possess a multitude of signaling functions. OPN although, is an extremely complex protein with several isoforms, proteolytic fragments and post-translational modifications that can function in contrasting roles in different conditions.

Finally, we have described two novel matricellular proteins, namely GRP78 and TRIP. The intracellular functions of these proteins have been studied extensively. However, we have recently unraveled some interesting extracellular functions for these proteins in mineralized tissue formation.

In conclusion, the various proteins and their functions reviewed here serve as an example of the complex nature of the ECM of mineralized tissues. Identifying and understanding the role of such multifaceted proteins would help in the treatment of mineralized tissue disorders such as osteoporosis, osteogenesis and dentinogenesis imperfecta.

Figure 1.

Figure 1

Immunohistochemical localization of DMPl, GRP-78 and Tripl: The figure represents the localization of DMPl, GRP-78 and Tripl in the calvaria and femur of 30 day wild type mice. The images are 3D reconstruction of z-stack confocal images of the respective sections immunostained with antibodies to the respective proteins. The area within the white lines in the femur section images represents the bone marrow. The white arrows in all images show the extracellular localization of the proteins.

Figure 2.

Figure 2

Hypothetical figure showing the role of multifunctional proteins in the formation of mineralized tissues:

Mesenchymal cells and their secreted ECM (A) are required for the formation of mineralized tissues. During development, the mesenchymal cells interact with the ECM (B) leading to ECM modification and differentiation of the cells into osteoblasts and osteocytes. This process results in the secretion of classical and non-classical ECM proteins that favor nucleation of hydroxyapatite such as DMPl (C) and also ones that control nucleation such as OPN (C) on the collagen matrix. These proteins orchestrate the process of hydroxyapatite nucleation on the collagen matrix (D) leading to the formation of mineralized tissues such as bone (E).

Acknowledgement

We acknowledge the support of NIH grants DE 19633, DE11657 and the Brodie Endowment Fund.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Reference

  • 1.Frantz C, Stewart KM, Weaver VM. The extracellular matrix at a glance. Journal of cell science. 2010;123:4195–4200. doi: 10.1242/jcs.023820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Ravindran S, Gao Q, Kotecha M, Magin RL, Karol S, Bedran-Russo A, George A. Biomimetic extracellular matrix-incorporated scaffold induces osteogenic gene expression in human marrow stromal cells. Tissue engineering. Part A. 2012;18:295–309. doi: 10.1089/ten.tea.2011.0136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Ravindran S, Zhang Y, Huang CC, George A. Odontogenic Induction of Dental Stem Cells by Extracellular Matrix-Inspired Three- Dimensional Scaffold. Tissue engineering. Part A. 2013 doi: 10.1089/ten.tea.2013.0192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Levorson EJ, Hu O, Mountziaris PM, Kasper FK, Mikos AG. Cell-Derived Polymer/Extracellular Matrix Composite Scaffolds for Cartilage Regeneration, Part 2: Construct Devitalization and Determination of Chondroinductive Capacity. Tissue engineering. Part C, Methods. 2013 doi: 10.1089/ten.tec.2013.0288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Levorson EJ, Mountziaris PM, Hu 0, Kasper FK, Mikos AG. Cell Derived Polymer/Extracellular Matrix Composite Scaffolds for Cartilage Regeneration, Part 1: Investigation of Co-cultures and Seeding Densities for Improved Extracellular Matrix Deposition. Tissue engineering. Part C, Methods. 2013 doi: 10.1089/ten.tec.2013.0286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Fukumoto S, Martin TJ. Bone as an endocrine organ. Trends in endocrinology and metabolism: TEM. 2009;20:230–236. doi: 10.1016/j.tem.2009.02.001. [DOI] [PubMed] [Google Scholar]
  • 7.Yoshiko Y, Wang H, Minamizaki T, Ijuin C, Yamamoto R, Suemune S, Kozai K, Tanne K, Aubin JE, Maeda N. Mineralized tissue cells are a principal source of FGF23. Bone. 2007;40:1565–1573. doi: 10.1016/j.bone.2007.01.017. [DOI] [PubMed] [Google Scholar]
  • 8.Street J, Bao M, deGuzman L, Bunting S, Peale FV, Jr, Ferrara N, Steinmetz H, Hoeffel J, Cleland JL, Daugherty A, van Bruggen N, Redmond HP, Carano RA, Filvaroff EH. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proceedings of the National Academy of Sciences of the United States of America. 2002;99:9656–9661. doi: 10.1073/pnas.152324099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Scheven BA, Man J, Millard JL, Cooper PR, Lea SC, Walmsley AD, Smith AJ. VEGF and odontoblast-like cells: stimulation by low frequency ultrasound. Archives of oral biology. 2009;54:185–191. doi: 10.1016/j.archoralbio.2008.09.008. [DOI] [PubMed] [Google Scholar]
  • 10.Feng JQ, Ward LM, Liu S, Lu Y, Xie Y, Yuan B, Yu X, Rauch F, Davis SI, Zhang S, Rios H, Drezner MK, Quarles LD, Bonewald LF, White KE. Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nature genetics. 2006;38:1310–1315. doi: 10.1038/ng1905. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Fen JQ, Zhang J, Dallas SL, Lu Y, Chen S, Tan X, Owen M, Harris SE, MacDougall M. Dentin matrix protein 1, a target molecule for Cbfal in bone, is a unique bone marker gene. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2002;17:1822–1831. doi: 10.1359/jbmr.2002.17.10.1822. [DOI] [PubMed] [Google Scholar]
  • 12.He G, Dahl T, Veis A, George A. Nucleation of apatite crystals in vitro by self-assembled dentin matrix protein 1. Nature materials. 2003;2:552–558. doi: 10.1038/nmat945. [DOI] [PubMed] [Google Scholar]
  • 13.He G, George A. Dentin matrix protein 1 immobilized on type I collagen fibrils facilitates apatite deposition in vitro. The Journal of biological chemistry. 2004;279:11649–11656. doi: 10.1074/jbc.M309296200. [DOI] [PubMed] [Google Scholar]
  • 14.Narayanan K, Ramachandran A, Hao J, He G, Park KW, Cho M, George A. Dual functional roles of dentin matrix protein 1. Implications in biomineralization and gene transcription by activation of intracellular Ca2+ store. The Journal of biological chemistry. 2003;278:17500–17508. doi: 10.1074/jbc.M212700200. [DOI] [PubMed] [Google Scholar]
  • 15.Narayanan K, Gajjeraman S, Ramachandran A, Hao J, George A. Dentin matrix protein 1 regulates dentin sialophosphoprotein gene transcription during early odontoblast differentiation. The Journal of biological chemistry. 2006;281:19064–19071. doi: 10.1074/jbc.M600714200. [DOI] [PubMed] [Google Scholar]
  • 16.Chaussain C, Eapen AS, Huet E, Floris C, Ravindran S, Hao J, Menashi S, George A. MMP2-cleavage of DMP1 generates a bioactive peptide promoting differentiation of dental pulp stem/progenitor cell. European cells & materials. 2009;18:84–95. doi: 10.22203/ecm.v018a08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Ravindran S, Narayanan K, Eapen AS, Hao J, Ramachandran A, Blond S, George A. Endoplasmic reticulum chaperone protein GRP-78 mediates endocytosis of dentin matrix protein 1. The Journal of biological chemistry. 2008;283:29658–29670. doi: 10.1074/jbc.M800786200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Eapen A, Sundivakkam P, Song Y, Ravindran S, Ramachandran A, Tiruppathi C, George A. Calcium-mediated stress kinase activation by DMP1 promotes osteoblast differentiation. The Journal of biological chemistry. 2010;285:36339–36351. doi: 10.1074/jbc.M110.145607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Wu H, Teng PN, Jayaraman T, Onishi S, Li J, Bannon L, Huang H, Close J, Sfeir C. Dentin matrix protein 1 (DMP1) signals via cell surface integrin. The Journal of biological chemistry. 2011;286:29462–29469. doi: 10.1074/jbc.M110.194746. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Qin C, Brunn JC, Cadena E, Ridall A, Butler WT. Dentin sialoprotein in bone and dentin sialophosphoprotein gene expressed by osteoblasts. Connective tissue research. 2003;44(Suppl 1):179–183. [PubMed] [Google Scholar]
  • 21.MacDougall M, Simmons D, Luan X, Nydegger J, Feng J, Gu TT. Dentin phosphoprotein and dentin sialoprotein are cleavage products expressed from a single transcript coded by a gene on human chromosome 4. Dentin phosphoprotein DNA sequence determination. The Journal of biological chemistry. 1997;111:835–842. doi: 10.1074/jbc.272.2.835. [DOI] [PubMed] [Google Scholar]
  • 22.von Marschall Z, Fisher LW. Dentin sialophosphoprotein (DSPP) is cleaved into its two natural dentin matrix products by three isoforms of bone morphogenetic protein-1 (BMP1) Matrix biology: journal of the International Society for Matrix Biology. 2010;29:295–303. doi: 10.1016/j.matbio.2010.01.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Yang RT, Lim GL, Dong Z, Lee AM, Yee CT, Fuller RS, Ritchie HH. The efficiency of dentin sialoprotein-phosphophoryn processing is affected by mutations both flanking and distant from the cleavage site. The Journal of biological chemistry. 2013;288:6024–6033. doi: 10.1074/jbc.M112.382952. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Ritchie HH, Yee CT, Tang XN, Dong Z, Fuller RS. DSP-PP precursor protein cleavage by tolloid-related-1 protein and by bone morphogenetic protein-1. PloS one. 2012;7:e41110. doi: 10.1371/journal.pone.0041110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Veis A. Mineral-matrix interactions in bone and dentin. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 1993;8(Suppl 2):S493–S497. doi: 10.1002/jbmr.5650081312. [DOI] [PubMed] [Google Scholar]
  • 26.George A, Bannon L, Sabsay B, Dillon JW, Malone J, Veis A, Jenkins NA, Gilbert DJ, Copeland NG. The carboxyl-terminal domain of phosphophoryn contains unique extended triplet amino acid repeat sequences forming ordered carboxyl-phosphate interaction ridges that may be essential in the biomineralization process. The Journal of biological chemistry. 1996;271:32869–32873. doi: 10.1074/jbc.271.51.32869. [DOI] [PubMed] [Google Scholar]
  • 27.George A, Hao J. Role of phosphophoryn in dentin mineralization. Cells, tissues, organs. 2005;181:232–240. doi: 10.1159/000091384. [DOI] [PubMed] [Google Scholar]
  • 28.He G, Ramachandran A, Dahl T, George S, Schultz D, Cookson D, Veis A, George A. Phosphorylation of phosphophoryn is crucial for its function as a mediator of biomineralization. The Journal of biological chemistry. 2005;280:33109–33114. doi: 10.1074/jbc.M500159200. [DOI] [PubMed] [Google Scholar]
  • 29.Sfeir C, Lee D, Li J, Zhang X, Boskey AL, Kumta PN. Expression of phosphophoryn is sufficient for the induction of matrix mineralization by mammalian cells. The Journal of biological chemistry. 2011;286:20228–20238. doi: 10.1074/jbc.M110.209528. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Eapen A, Ramachandran A, George A. DPP in the matrix mediates cell adhesion but is not restricted to stickiness: a tale of signaling. Cell adhesion & migration. 2012;6:307–311. doi: 10.4161/cam.20627. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Eapen A, Ramachandran A, George A. Dentin phosphoprotein (DPP) activates integrin-mediated anchorage-dependent signals in undifferentiated mesenchymal cells. The Journal of biological chemistry. 2012;287:5211–5224. doi: 10.1074/jbc.M111.290080. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Eapen A, Kulkarni R, Ravindran S, Ramachandran A, Sundivakkam P, Tiruppathi C, George A. Dentin phosphophoryn activates Smad protein signaling through Ca2+-calmodulin-dependent protein kinase II in undifferentiated mesenchymal cells. The Journal of biological chemistry. 2013;288:8585–8595. doi: 10.1074/jbc.M112.413997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Ravindran S, Snee PT, Ramachandran A, George A. Acidic domain in dentin phosphophoryn facilitates cellular uptake: implications in targeted protein delivery. The Journal of biological chemistry. 2013;288:16098–16109. doi: 10.1074/jbc.M113.450585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Sodek J, Ganss B, McKee MD. Osteopontin. Critical reviews in oral biology and medicine: an official publication of the American Association of Oral Biologists. 2000;11:279–303. doi: 10.1177/10454411000110030101. [DOI] [PubMed] [Google Scholar]
  • 35.Denhardt DT, Guo X. Osteopontin: a protein with diverse functions. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 1993;7:1475–1482. [PubMed] [Google Scholar]
  • 36.Mi Z, Guo H, Kuo PC. Identification of osteopontin-dependent signaling pathways in a mouse model of human breast cancer. BMC research notes. 2009;2:119. doi: 10.1186/1756-0500-2-119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Wilson MJ, Liaw L, Koopman P. Osteopontin and related SIBLING glycoprotein genes are expressed by Sertoli cells during mouse testis development. Developmental dynamics: an official publication of the American Association of Anatomists. 2005;233:1488–1495. doi: 10.1002/dvdy.20456. [DOI] [PubMed] [Google Scholar]
  • 38.McKee MD, Nanci A. Osteopontin: an interfacial extracellular matrix protein in mineralized tissues. Connective tissue research. 1996;35:197–205. doi: 10.3109/03008209609029192. [DOI] [PubMed] [Google Scholar]
  • 39.Thurner PJ, Chen CG, Ionova-Martin S, Sun L, Harman A, Porter A, Ager JW, 3rd, Ritchie RO, Alliston T. Osteopontin deficiency increases bone fragility but preserves bone mass. Bone. 2010;46:1564–1573. doi: 10.1016/j.bone.2010.02.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Hunter GK, Hauschka PV, Poole AR, Rosenberg LC, Goldberg HA. Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins. The Biochemical journal. 1996;317(Pt 1):59–64. doi: 10.1042/bj3170059. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Qiu SR, Wierzbicki A, Orme CA, Cody AM, Hoyer JR, Nancollas GH, Zepeda S, De Yoreo JJ. Molecular modulation of calcium oxalate crystallization by osteopontin and citrate. Proceedings of the National Academy of Sciences of the United States of America. 2004;101:1811–1815. doi: 10.1073/pnas.0307900100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Giachelli CM, Steitz S. Osteopontin: a versatile regulator of inflammation and biomineralization. Matrix biology -.journal of the International Society for Matrix Biology. 2000;19:615–622. doi: 10.1016/s0945-053x(00)00108-6. [DOI] [PubMed] [Google Scholar]
  • 43.Gericke A, Qin C, Spevak L, Fujimoto Y, Butler WT, Sorensen ES, Boskey AL. Importance of phosphorylation for osteopontin regulation of biomineralization. Calcified tissue international. 2005;11:45–54. doi: 10.1007/s00223-004-1288-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Agnihotri R, Crawford HC, Haro H, Matrisian LM, Havrda MC, Liaw L. Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin) The Journal of biological chemistry. 2001;276:28261–28267. doi: 10.1074/jbc.M103608200. [DOI] [PubMed] [Google Scholar]
  • 45.Dean RA, Overall CM. Proteomics discovery of metalloproteinase substrates in the cellular context by iTRAQ labeling reveals a diverse MMP-2 substrate degradome. Molecular & cellular proteomics: MCP. 2007;6:611–623. doi: 10.1074/mcp.M600341-MCP200. [DOI] [PubMed] [Google Scholar]
  • 46.Forsprecher J, Wang Z, Goldberg HA, Kaartinen MT. Transglutaminase-mediated oligomerization promotes osteoblast adhesive properties of osteopontin and bone sialoprotein. Cell adhesion & migration. 2011;5:65–72. doi: 10.4161/cam.5.1.13369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Zohar R, Suzuki N, Suzuki K, Arora P, Glogauer M, McCulloch CA, Sodek J. Intracellular osteopontin is an integral component of the CD44-ERM complex involved in cell migration. Journal of cellular physiology. 2000;184:118–130. doi: 10.1002/(SICI)1097-4652(200007)184:1<118::AID-JCP13>3.0.CO;2-Y. [DOI] [PubMed] [Google Scholar]
  • 48.Suzuki K, Zhu B, Rittling SR, Denhardt DT, Goldberg HA, McCulloch CA, Sodek J. Colocalization of intracellular osteopontin with CD44 is associated with migration, cell fusion, and resorption in osteoclasts. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2002;17:1486–1497. doi: 10.1359/jbmr.2002.17.8.1486. [DOI] [PubMed] [Google Scholar]
  • 49.Zhu B, Suzuki K, Goldberg HA, Rittling SR, Denhardt DT, McCulloch CA, Sodek J. Osteopontin modulates CD44-dependent chemotaxis of peritoneal macrophages through G-protein-coupled receptors: evidence of a role for an intracellular form of osteopontin. Journal of cellular physiology. 2004;198:155–167. doi: 10.1002/jcp.10394. [DOI] [PubMed] [Google Scholar]
  • 50.Shinohara ML, Kim HJ, Kim JH, Garcia VA, Cantor H. Alternative translation of osteopontin generates intracellular and secreted isoforms that mediate distinct biological activities in dendritic cells. Proceedings of the National Academy of Sciences of the United States of America. 2008;105:7235–7239. doi: 10.1073/pnas.0802301105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Junaid A, Moon MC, Harding GE, Zahradka P. Osteopontin localizes to the nucleus of 293 cells and associates with polo-like kinase-1. American journal of physiology. Cell physiology. 2007;292:C919–C926. doi: 10.1152/ajpcell.00477.2006. [DOI] [PubMed] [Google Scholar]
  • 52.Takeshita S, Kikuno R, Tezuka K, Amann E. Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I. The Biochemical journal. 1993;294(Pt 1):271–278. doi: 10.1042/bj2940271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Merle B, Garnero P. The multiple facets of periostin in bone metabolism. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2012;23:1199–1212. doi: 10.1007/s00198-011-1892-7. [DOI] [PubMed] [Google Scholar]
  • 54.Ma D, Zhang R, Sun Y, Rios HF, Haruyama N, Han X, Kulkarni AB, Qin C, Feng JQ. A novel role of periostin in postnatal tooth formation and mineralization. The Journal of biological chemistry. 2011;286:4302–4309. doi: 10.1074/jbc.M110.140202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Sugiura T, Takamatsu H, Kudo A, Amann E. Expression and characterization of murine osteoblast-specific factor 2 (OSF-2) in a baculovirus expression system. Protein expression and purification. 1995;6:305–311. doi: 10.1006/prep.1995.1040. [DOI] [PubMed] [Google Scholar]
  • 56.Litvin J, Selim AH, Montgomery MO, Lehmann K, Rico MC, Devlin H, Bednarik DP, Safadi FF. Expression and function of periostin- isoforms in bone. Journal of cellular biochemistry. 2004;92:1044–1061. doi: 10.1002/jcb.20115. [DOI] [PubMed] [Google Scholar]
  • 57.Delpino A, Castelli M. The 78 kDa glucose-regulated protein (GRP78/BIP) is expressed on the cell membrane, is released into cell culture medium and is also present in human peripheral circulation. Bioscience reports. 2002;22:407–420. doi: 10.1023/a:1020966008615. [DOI] [PubMed] [Google Scholar]
  • 58.Altmeyer A, Maki RG, Feldweg AM, Heike M, Protopopov VP, Masur SK, Srivastava PK. Tumor-specific cell surface expression of the- KDEL containing, endoplasmic reticular heat shock protein gp96. International journal of cancer. Journal international du cancer. 1996;69:340–349. doi: 10.1002/(SICI)1097-0215(19960822)69:4<340::AID-IJC18>3.0.CO;2-9. [DOI] [PubMed] [Google Scholar]
  • 59.Wiest DL, Bhandoola A, Punt J, Kreibich G, McKean D, Singer A. Incomplete endoplasmic reticulum (ER) retention in immature thymocytes as revealed by surface expression of"ER-resident" molecular chaperones. Proceedings of the National Academy of Sciences of the United States of America. 1997;94:1884–1889. doi: 10.1073/pnas.94.5.1884. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Xiao G, Chung TF, Pyun HY, Fine RE, Johnson RJ. KDEL proteins are found on the surface of NG108-15 cells. Brain research. Molecular brain research. 1999;72:121–128. doi: 10.1016/s0169-328x(99)00188-6. [DOI] [PubMed] [Google Scholar]
  • 61.Broquet AH, Thomas G, Masliah J, Trugnan G, Bachelet M. Expression of the molecular chaperone Hsp70 in detergent-resistant microdomains correlates with its membrane delivery and release. The Journal of biological chemistry. 2003;278:21601–21606. doi: 10.1074/jbc.M302326200. [DOI] [PubMed] [Google Scholar]
  • 62.Triantafilou K, Fradelizi D, Wilson K, Triantafilou M. GRP78, a coreceptor for coxsackievirus A9, interacts with major histocompatibility complex class I molecules which mediate virus internalization. Journal of virology. 2002;76:633–643. doi: 10.1128/JVI.76.2.633-643.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Ravindran S, Gao Q, Ramachandran A, Blond S, Predescu SA, George A. Stress chaperone GRP-78 functions in mineralized matrix formation. The Journal of biological chemistry. 2011;286:8729–8739. doi: 10.1074/jbc.M110.179341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Ravindran S, Gao Q, Ramachandran A, Sundivakkam P, Tiruppathi C, George A. Expression and distribution of grp-78/bip in mineralizing tissues and mesenchymal cells. Histochemistry and cell biology. 2012;138:113–125. doi: 10.1007/s00418-012-0952-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Neer EJ, Schmidt CJ, Nambudripad R, Smith TF. The ancient regulatory-protein family of WD-repeat proteins. Nature. 1994;371:297–300. doi: 10.1038/371297a0. [DOI] [PubMed] [Google Scholar]
  • 66.Smith TF, Gaitatzes C, Saxena K, Neer EJ. The WD repeat: a common architecture for diverse functions. Trends in biochemical sciences. 1999;24:181–185. doi: 10.1016/s0968-0004(99)01384-5. [DOI] [PubMed] [Google Scholar]
  • 67.Choy L, Derynck R. The type II transforming growth factor (TGF)-beta receptor-interacting protein TRIP-1 acts as a modulator of the TGF-beta response. The Journal of biological chemistry. 1998;273:31455–31462. doi: 10.1074/jbc.273.47.31455. [DOI] [PubMed] [Google Scholar]
  • 68.Ramachandran A, Ravindran S, George A. Localization of transforming growth factor beta receptor II interacting protein-1 in bone and teeth: implications in matrix mineralization. The journal of histochemistry and cytochemistry: official journal of the Histochemistry Society. 2012;60:323–337. doi: 10.1369/0022155412436879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Unterbrink A, O'Sullivan M, Chen S, MacDougall M. TGF beta-1 downregulates DMP-1 and DSPP in odontoblasts. Connective tissue research. 2002;43:354–358. doi: 10.1080/03008200290000565. [DOI] [PubMed] [Google Scholar]
  • 70.Alves RD, Demmers JA, Bezstarosti K, van der Eerden BC, Verhaar JA, Eijken M, van Leeuwen JP. Unraveling the human bone microenvironment beyond the classical extracellular matrix proteins: a human bone protein library. Journal ofproteome research. 2011;10:4725–4733. doi: 10.1021/pr200522n. [DOI] [PubMed] [Google Scholar]

RESOURCES